Finance

Lists
688185:SHA
Cansino Biologics Inc
82,91 CN¥
+0,25%
(+0,21) 1D
16 հոկ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688185...
Open
84,00 CN¥
High
91,60 CN¥
Low
82,16 CN¥
Mkt. cap
12,91 մլրդ
Avg. vol.
10,80 մլն
Volume
12,04 մլն
P/E ratio
422,82
52-wk high
108,00 CN¥
52-wk low
46,89 CN¥
EPS
0,20 CN¥
No. of employees
1 հզր
Open
84,00 CN¥
High
91,60 CN¥
Low
82,16 CN¥
Mkt. cap
12,91 մլրդ
Avg. vol.
10,80 մլն
Volume
12,04 մլն
P/E ratio
422,82
52-wk high
108,00 CN¥
52-wk low
46,89 CN¥
EPS
0,20 CN¥
No. of employees
1 հզր
News stories
From web sources and news partners
Profile
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
About Cansino Biologics Inc
CEOXuefeng Yu
Employees1,18 հզր
Founded13 հնվ, 2009 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
310,24 մլն
375,34 մլն
190,28 մլն
359,54 մլն
Cost of goods sold
55,37 մլն
129,82 մլն
36,26 մլն
97,60 մլն
Cost of revenue
55,37 մլն
129,82 մլն
36,26 մլն
97,60 մլն
Research and development expenses
76,87 մլն
88,37 մլն
71,41 մլն
84,08 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158,60 մլն
187,81 մլն
116,85 մլն
158,72 մլն
Operating expense
218,49 մլն
325,84 մլն
182,92 մլն
258,68 մլն
Total operating expenses
273,86 մլն
455,66 մլն
219,19 մլն
356,28 մլն
Operating income
36,38 մլն
-80,32 մլն
-28,90 մլն
3,26 մլն
Other non operating income
-8,06 մլն
5,34 մլն
-9,91 մլն
7,97 մլն
EBT including unusual items
27,79 մլն
13,25 մլն
-34,38 մլն
40,42 մլն
EBT excluding unusual items
40,15 մլն
-74,47 մլն
-36,57 մլն
-3,72 մլն
Income tax expense
-134,75 հզր
-181,72 հզր
6,04 մլն
714,36 հզր
Effective tax rate
-0,48%
-1,37%
-17,58%
1,77%
Other operating expenses
-15,79 մլն
50,87 մլն
-9,21 մլն
12,43 մլն
Net income
27,93 մլն
13,43 մլն
-40,42 մլն
39,70 մլն
Net profit margin
9,00%
3,58%
-21,24%
11,04%
Earnings per share
-
-
-
-
Interest and investment income
13,97 մլն
21,09 մլն
9,43 մլն
12,84 մլն
Interest expense
-11,11 մլն
-3,20 մլն
-7,19 մլն
-5,91 մլն
Net interest expenses
2,86 մլն
17,88 մլն
2,24 մլն
6,92 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
82,74 մլն
-39,25 մլն
12,18 մլն
49,79 մլն
Gain or loss from assets sale
84,72 հզր
-137,05 հզր
-
-
AI content may include mistakes. Learn more
Google Apps